Stifel Nicolaus Keeps Their Buy Rating on Critical Elements (CRECF)
Stifel Nicolaus analyst Cole McGill maintained a Buy rating on Critical Elements (CRECF – Research Report) today and set a price target of ...
Stifel maintains GMED buy rating, $92 target amid NVRO buyout
Stifel analysts maintained a Buy rating and a $92.00 price target for Globus Medical (NYSE:GMED) stock following the company's announcement of acquiring Nevro Corp . (NYSE:NVRO) for an equity value of ...
Stifel Nicolaus Sticks to Their Buy Rating for Astera Labs, Inc. (ALAB)
In a report released today, Tore Svanberg from Stifel Nicolaus maintained a Buy rating on Astera Labs, Inc. (ALAB – Research Report), with a ...